T Man Pharmaceutical PCL
SET:TMAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
TH |
|
D
|
DA Technology Co Ltd
KOSDAQ:196490
|
KR |
|
MNC Asia Holding Tbk PT
IDX:BHIT
|
ID |
|
C
|
Cydsa SAB de CV
BMV:CYDSASAA
|
MX |
|
CMS Energy Corp
NYSE:CMS
|
US |
|
A
|
Adaptive Plasma Technology Corp
KOSDAQ:089970
|
KR |
|
American Energy Partners Inc
OTC:AEPT
|
US |
|
HC SemiTek Corp
SZSE:300323
|
CN |
|
A
|
Autocorp Holding PCL
SET:ACG
|
TH |
Income Statement
Earnings Waterfall
T Man Pharmaceutical PCL
Income Statement
T Man Pharmaceutical PCL
| Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue |
2 220
N/A
|
2 231
+1%
|
2 354
+5%
|
2 506
+6%
|
|
| Gross Profit | |||||
| Cost of Revenue |
(1 141)
|
(1 126)
|
(1 232)
|
(1 338)
|
|
| Gross Profit |
1 079
N/A
|
1 105
+2%
|
1 122
+2%
|
1 168
+4%
|
|
| Operating Income | |||||
| Operating Expenses |
(546)
|
(558)
|
(555)
|
(577)
|
|
| Selling, General & Administrative |
(563)
|
(577)
|
(577)
|
(597)
|
|
| Other Operating Expenses |
16
|
19
|
22
|
20
|
|
| Operating Income |
532
N/A
|
547
+3%
|
567
+4%
|
591
+4%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
(23)
|
(28)
|
(33)
|
(28)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
57
|
|
| Total Other Income |
2
|
(1)
|
(5)
|
(6)
|
|
| Pre-Tax Income |
511
N/A
|
519
+1%
|
529
+2%
|
614
+16%
|
|
| Net Income | |||||
| Tax Provision |
(78)
|
(78)
|
(80)
|
(91)
|
|
| Income from Continuing Operations |
433
|
441
|
449
|
523
|
|
| Income to Minority Interest |
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Income (Common) |
433
N/A
|
441
+2%
|
449
+2%
|
523
+16%
|
|
| EPS (Diluted) |
1.08
N/A
|
1.1
+2%
|
1.12
+2%
|
1.31
+17%
|
|